Newest first. 5.2k questions across 107 tags.
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
Setup, so nobody has to ask: 2–8 °C · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
Concretely: WXT · identity confirmation by mass spectrometry. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
The specifics, since they change the answer: WXT · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is…
Setup, so nobody has to ask: LDL-C · a GLP-1 receptor agonist. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
What I am working with: 97.9% · a C18 column · ecnoglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
What I have: mazdutide · sixteen weeks · 4 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Details up front: a GLP-1 receptor agonist · a C8 column · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason.…
Concretely: SELECT · nausea. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which is…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
What I have: a GLP-1 receptor agonist · 0.5 mg. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I…
Concretely: Wuxi · Ireland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which is…
Concretely: Wuxi · Singapore. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which is…
What I have: Hangzhou · Singapore. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: ApoB · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
The lane and the lead time matter as much as the material for what I am doing. This is presented as though it settles something, and I am not convinced it does. I…
What I have: vomiting · retatrutide · TRIUMPH-1. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The pharmacy is accredited and I have verified that on the accreditor register. I am trying to do this correctly the first time rather than learn it by getting it…
Concretely: semaglutide · 2 mg/mL · three weeks. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
The case in front of me: list of related substances · SSA. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow…
Conditions: 2.5 mg · 0.5 mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the value…
The vial was lyophilised at the time, which I understand may matter a great deal. I want to know whether there is evidence behind this or only repetition. I have…
The specifics, since they change the answer: Suzhou · Australia. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
The case in front of me: ecnoglutide · 2 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…